Mamografide Mikrokalsifikasyon Tespit Edilen Hastalarda Kontrastlı Spektral Mamografi ile Dinamik Meme MRG’nin Etkinliğinin Karşılaştırılması: Tek Merkez Deneyimi

Aim: The aim of this study is to compare the diagnostic performance of contrast-enhanced spectral mammography (CESM) and breast magnetic resonance imaging (MRI) in patients with microcalcification detected by mammography. CESM and MRI the for in the study, the that the were diagnosed histopathologically and that both CESM and Breast were performed were sought. The presence of pathological enhancement for CESM and Breast MRI compared statistically using the Fisher-Freeman-Halton Exact test together with histopathological diagnosis. CESM and Breast MRI examinations were performed in 75 patients with microcalcifications. Pathological contrast enhancement was detected in 47 cases in breast MRI examinations of these patients. With CESM examination, 49 patients had contrast enhancement in the microcalcification region. Forty-seven patients with contrast enhancement with both examinations were common. Contrast enhancement rates of those who were found benign as a result of the biopsy were the same for CESM and MRI (48.9%). Contrast enhancement rates of malignant ones for CESM, 88% for MRI, and 60% for CESM and Breast MRI for premalignant lesions. When contrast enhancement of the lesions was compared according to the biopsy results, no statistically significant difference was found for CESM and Breast MRI. Conclusion: CESM shows less background enhancement and has a similar sensitivity to breast MRI in detecting breast cancer. CESM is an easily accessible alternative to Breast MRI and the procedure time is significantly shorter. For these reasons, it has the potential to play an important role in breast cancer detection and staging.